Irritable Bowel Syndrome Stories
If you are suffering from Irritable Bowel Syndrome (IBS), you can thank your guts. An overgrowth of gut bacteria has been linked to causing IBS.
The molecular mechanism of the active ingredient in castor oil, used for many centuries as a laxative and labor-inducer, has been found.
Patients with inflammatory bowel disease and other gastrointestinal disorders may be exposed to significant doses of diagnostic radiation, according to a new study. Patients with irritable bowel syndrome have a significantly greater prevalence of early adverse life events, including general trauma as well as physical, emotional and sexual abuse, according to a new study. Researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people. The American College of Gastroenterology published a new evidence-based systematic review on the management of Inflammatory Bowel Disease (IBD) as a supplement to The American Journal of Gastroenterology (AJG) for April 2011, a special issue entirely dedicated to IBD. Children and adolescents growing up with inflammatory bowel disease (IBD) are less fit than their peers, says a study by researchers at McMaster University and the McMaster Children's Hospital. A ground-breaking antibiotic therapy developed at Cedars-Sinai Medical Center is the first potential drug treatment to provide irritable bowel syndrome patients with long-lasting relief of their symptoms even after they stop taking the medication, according to a study published in the Jan. 6 issue of the New England Journal of Medicine. An international team of researchers led by the University of East Anglia (UEA) have developed a new kind of endoscope to aid the early detection and diagnosis of inflammatory bowel disease. Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Home to a diverse range of microorganisms, a healthy human body contains at least tenfold more bacteria cells than human cells. The most abundant and diverse microbial community resides in the intestine, and changes to the gut microbiota are linked with diseases such as ulcerative colitis and Crohn's disease. In a report published online today in Genome Research(www.genome.org), researchers have analyzed the long-term effects of gut bacterial transplantation in rats, revealing crucial insight that will aid in the development of new treatments.